Kodikaz Therapeutic Solutions, founded with the mission to revolutionize cancer treatment, focuses on developing durable cures through targeted gene therapies. Utilizing their proprietary Zip-Code™ Technology platform, Kodikaz offers a first-in-class, cell-specific delivery system designed for a broad range of cell and gene therapy applications. Their vision is to move beyond incremental cancer therapies with severe side effects to innovative solutions that can completely eradicate cancers.

The company boasts a team of experienced and passionate professionals dedicated to advancing next-generation therapeutic products. Notable achievements include the development of their unique Zip-Code™ Technology, which has positioned them as a leader in the gene therapy space. With significant backing from investors and advisors in the biotech industry, Kodikaz is making substantial strides in the fight against cancer, aiming to deliver more effective and less harmful treatment options to patients worldwide.